Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Helle

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Viral Hepatitis|August 4, 2017
Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virusC Fournier, T W Hoffmann, V Morel, et al.
Journal of Clinical Microbiology|December 14, 2011
Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patientsV Descamps, A Op de Beeck, C Plassart, et al.
The Journal of Nutrition, Health & Aging|January 24, 2022
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care FacilitiesJ Moyet, F Helle, G Bourdenet, et al.
Journal of Viral Hepatitis|November 20, 2008
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trialL Alvarez-Lajonchere, N H Shoukry, B Grá, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Viral Hepatitis|August 4, 2017
Claudin-1, miR-122 and apolipoprotein E transductions improve the permissivity of SNU-182, SNU-398 and SNU-449 hepatoma cells to hepatitis C virusC Fournier, T W Hoffmann, V Morel, et al.
Journal of Clinical Microbiology|December 14, 2011
Strong correlation between liver and serum levels of hepatitis C virus core antigen and RNA in chronically infected patientsV Descamps, A Op de Beeck, C Plassart, et al.
The Journal of Nutrition, Health & Aging|January 24, 2022
Kinetics of SARS-CoV-2-Neutralising Antibodies of Residents of Long-Term Care FacilitiesJ Moyet, F Helle, G Bourdenet, et al.
Journal of Viral Hepatitis|November 20, 2008
Immunogenicity of CIGB-230, a therapeutic DNA vaccine preparation, in HCV-chronically infected individuals in a Phase I clinical trialL Alvarez-Lajonchere, N H Shoukry, B Grá, et al.
Pageof 2